Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Patrizia Mondello

Showing results (11-20 of 92) with videos related to

Pageof 10
Sort By:
Journal of Hematology & Oncology|December 11, 2014
Pim kinases in hematological malignancies: where are we now and where are we going?Patrizia Mondello, Salvatore Cuzzocrea, Michael Mian
Critical Reviews in Oncology/Hematology|July 12, 2019
Primary central nervous system lymphoma: Novel precision therapiesPatrizia Mondello, Michael Mian, Francesco Bertoni
Frontiers in Immunology|November 18, 2024
Unraveling the role of cancer-associated fibroblasts in B cell lymphomaPrithviraj Mukherjee, Stephen M Ansell, Patrizia Mondello
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Questionable validity of cardiac risk score on the basis of the NSABP B-31 modelVincenzo Pitini, Carmela Arrigo, Patrizia Mondello, et al.
Springerplus|July 22, 2014
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseasePatrizia Mondello, Michael Mian, Carmela Arrigo, et al.
Oncotarget|January 19, 2017
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progressionPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Frontiers in Genetics|March 3, 2022
Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell LymphomaPatrizia Mondello, Stephen M Ansell, Grzegorz S Nowakowski
Oncotarget|December 15, 2015
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 28, 2022
Insights into the tumor microenvironment of B cell lymphomaWern Lynn Ng, Stephen M Ansell, Patrizia Mondello
Anticancer Research|September 10, 2014
90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatmentPatrizia Mondello, Vincenzo Pitini, Carmela Arrigo, et al.
Pageof 10

Showing results (11-20 of 92) with videos related to

Sort By:
Pageof 10
Journal of Hematology & Oncology|December 11, 2014
Pim kinases in hematological malignancies: where are we now and where are we going?Patrizia Mondello, Salvatore Cuzzocrea, Michael Mian
Critical Reviews in Oncology/Hematology|July 12, 2019
Primary central nervous system lymphoma: Novel precision therapiesPatrizia Mondello, Michael Mian, Francesco Bertoni
Frontiers in Immunology|November 18, 2024
Unraveling the role of cancer-associated fibroblasts in B cell lymphomaPrithviraj Mukherjee, Stephen M Ansell, Patrizia Mondello
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|May 8, 2013
Questionable validity of cardiac risk score on the basis of the NSABP B-31 modelVincenzo Pitini, Carmela Arrigo, Patrizia Mondello, et al.
Springerplus|July 22, 2014
Primary diffuse large B-cell lymphoma of the bone: bendamustine and rituximab are able to overcome resistant diseasePatrizia Mondello, Michael Mian, Carmela Arrigo, et al.
Oncotarget|January 19, 2017
Bone marrow micro-environment is a crucial player for myelomagenesis and disease progressionPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Frontiers in Genetics|March 3, 2022
Immune Epigenetic Crosstalk Between Malignant B Cells and the Tumor Microenvironment in B Cell LymphomaPatrizia Mondello, Stephen M Ansell, Grzegorz S Nowakowski
Oncotarget|December 15, 2015
90 Y-ibritumomab tiuxetan: a nearly forgotten opportunityrPatrizia Mondello, Salvatore Cuzzocrea, Michele Navarra, et al.
Journal of Experimental & Clinical Cancer Research : CR|December 28, 2022
Insights into the tumor microenvironment of B cell lymphomaWern Lynn Ng, Stephen M Ansell, Patrizia Mondello
Anticancer Research|September 10, 2014
90Y-Ibritumomab Tiuxetan consolidation after autologous stem cell transplantation improves survival of patients with intermediate-/high-risk diffuse large B-cell lymphoma not responding adequately to first-line treatmentPatrizia Mondello, Vincenzo Pitini, Carmela Arrigo, et al.
Pageof 10